POTTERS BAR, England, April 27, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) announced today that it will host a conference call and live webcast on Tuesday, May 5, 2015, at 4:30 p.m. ET, to review the company's financial results for the first quarter ended March 31, 2015 and to provide an update on the proposed acquisition of Perrigo. Mylan will release its financial results on May 5 after the market closes.
The dial-in number to access the call is 800.514.4861 or 678.809.2405 for international callers. To access the live webcast, please log on to Mylan's website, mylan.com, at least 15 minutes before the event is scheduled to begin to register and download or install any necessary software. A replay of the webcast will be available at mylan.com/investors, for a limited time.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. Our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com
SOURCE Mylan N.V.